Chocolate Heart, a New Drug Coated PTCA Balloon Cleared in Europe
 

Chocolate Heart, a New Drug Coated PTCA Balloon Cleared in Europe
http://www.medgadget.com/wp-content/...07/TriReme.jpg

TriReme Medical (Pleasanton, California), part of*QT Vascular, a company based in Singapore, received European regulatory approval for its new Chocolate Heart drug-coated percutaneous transluminal coronary angioplasty (PTCA) balloon for pushing apart ste**ses in the coronary arteries. It’s a paclitaxel coated version of*the Chocolate PTCA balloon, a device cleared*in the U.S. a couple years ago.

The company believes the drug coating will provide some patients the ability to receive treatment without leaving a stent behind.

From QT Vascular:

The FIH study of Chocolate Heart™ was conducted at CECA**T Hospital in Santo Domingo, Dominican Republic in 19 patients with de **vo coronary lesions. The results of this **vel study were recently presented by the IVUS core lab principal investigator, Dr. Alexandre Abizaid of Dante Pazzanese Hospital in Sao Paolo, Brazil. In-hospital and after 30 days, the incidence of acute closure was 0% compared to over 9%2 for conventional balloon angioplasty. At 6 months, the late lumen loss was only 0.01mm with a rate of target lesion re-treatment of only 5%.

Flashback:*Chocolate PTCA Balloon for Coronary Ste**sis Dilation Cleared in U.S…

Via:*QT Vascular…

This post Chocolate Heart, a New Drug Coated PTCA Balloon Cleared in Europe appeared first on Medgadget.

http://feeds.feedburner.com/~ff/Medgadget?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/Medgadget?d=qj6IDK7rITs http://feeds.feedburner.com/~ff/Medg...y4:gIN9vFwOqvQ
http://feeds.feedburner.com/~r/Medgadget/~4/6KCFeYfbRJY